SUGAR LAND--January 20, 2015--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--As the first quarter of 2015 gathers steam, the Pharmaceutical-Biotech Industry is projected to launch $3.9 billion worth of North American projects through the end of March. A healthy cash injection of that magnitude is cause for jubilation, or at the least, cautious optimism. Within this article: Details on the industry's North American kickoffs in first-quarter 2015, including major projects from AstraZeneca (NYSE:AZN), Gilead Sciences (NASDAQ:GILD) and the U.S. Army Public Health Command.
(All Fields Required)
Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.
×Contact Us
For More Info!
